Formation of sustained antitumor effect in mice’s liver and spleen (CBA х C57BL/6)F1 after a single intravenous injection of zymosan-treated neutrophils
Application of zymosan in medicine is limited because of its side effects, since the native granules of zymosan directly activate serum complement components and phagocytic cells. In this regard, it was decided at the outset (ex vivo) to incorporate the granules of zymosan in the neutrophils, and on...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
Scientific Сentre for Family Health and Human Reproduction Problems
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/820d9422bfb04e079b7c77e941d3681f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:820d9422bfb04e079b7c77e941d3681f |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:820d9422bfb04e079b7c77e941d3681f2021-11-23T06:14:36ZFormation of sustained antitumor effect in mice’s liver and spleen (CBA х C57BL/6)F1 after a single intravenous injection of zymosan-treated neutrophils2541-94202587-959610.12737/23403https://doaj.org/article/820d9422bfb04e079b7c77e941d3681f2016-09-01T00:00:00Zhttps://www.actabiomedica.ru/jour/article/view/289https://doaj.org/toc/2541-9420https://doaj.org/toc/2587-9596Application of zymosan in medicine is limited because of its side effects, since the native granules of zymosan directly activate serum complement components and phagocytic cells. In this regard, it was decided at the outset (ex vivo) to incorporate the granules of zymosan in the neutrophils, and only then inject these "loaded" zymosan neutrophils into the bloodstream. Our experiments showed a total inhibition of the weight accretion of both tumor affected liver (from 5220 ± 963 to 1327 ± 219 mg) and spleen (from 328 ± 29 to 187 ± 64 mg) of mice. Thus these data showed that even on the 17th day after a single intravenous injection zymosan-treated neutrophils persist expressed manifestations of anti-tumor activity in the liver and spleen, that may be basis for using this method for antimetastatic preventive measures in liver and other localizations.A. G. LyubimovG. Y. LyubimovV. A. KozlovScientific Сentre for Family Health and Human Reproduction Problemsarticlemelanomaneutrophilszymosanglucanliver tumorsspleenScienceQRUActa Biomedica Scientifica, Vol 1, Iss 5, Pp 110-113 (2016) |
institution |
DOAJ |
collection |
DOAJ |
language |
RU |
topic |
melanoma neutrophils zymosan glucan liver tumors spleen Science Q |
spellingShingle |
melanoma neutrophils zymosan glucan liver tumors spleen Science Q A. G. Lyubimov G. Y. Lyubimov V. A. Kozlov Formation of sustained antitumor effect in mice’s liver and spleen (CBA х C57BL/6)F1 after a single intravenous injection of zymosan-treated neutrophils |
description |
Application of zymosan in medicine is limited because of its side effects, since the native granules of zymosan directly activate serum complement components and phagocytic cells. In this regard, it was decided at the outset (ex vivo) to incorporate the granules of zymosan in the neutrophils, and only then inject these "loaded" zymosan neutrophils into the bloodstream. Our experiments showed a total inhibition of the weight accretion of both tumor affected liver (from 5220 ± 963 to 1327 ± 219 mg) and spleen (from 328 ± 29 to 187 ± 64 mg) of mice. Thus these data showed that even on the 17th day after a single intravenous injection zymosan-treated neutrophils persist expressed manifestations of anti-tumor activity in the liver and spleen, that may be basis for using this method for antimetastatic preventive measures in liver and other localizations. |
format |
article |
author |
A. G. Lyubimov G. Y. Lyubimov V. A. Kozlov |
author_facet |
A. G. Lyubimov G. Y. Lyubimov V. A. Kozlov |
author_sort |
A. G. Lyubimov |
title |
Formation of sustained antitumor effect in mice’s liver and spleen (CBA х C57BL/6)F1 after a single intravenous injection of zymosan-treated neutrophils |
title_short |
Formation of sustained antitumor effect in mice’s liver and spleen (CBA х C57BL/6)F1 after a single intravenous injection of zymosan-treated neutrophils |
title_full |
Formation of sustained antitumor effect in mice’s liver and spleen (CBA х C57BL/6)F1 after a single intravenous injection of zymosan-treated neutrophils |
title_fullStr |
Formation of sustained antitumor effect in mice’s liver and spleen (CBA х C57BL/6)F1 after a single intravenous injection of zymosan-treated neutrophils |
title_full_unstemmed |
Formation of sustained antitumor effect in mice’s liver and spleen (CBA х C57BL/6)F1 after a single intravenous injection of zymosan-treated neutrophils |
title_sort |
formation of sustained antitumor effect in mice’s liver and spleen (cba х c57bl/6)f1 after a single intravenous injection of zymosan-treated neutrophils |
publisher |
Scientific Сentre for Family Health and Human Reproduction Problems |
publishDate |
2016 |
url |
https://doaj.org/article/820d9422bfb04e079b7c77e941d3681f |
work_keys_str_mv |
AT aglyubimov formationofsustainedantitumoreffectinmicesliverandspleencbahc57bl6f1afterasingleintravenousinjectionofzymosantreatedneutrophils AT gylyubimov formationofsustainedantitumoreffectinmicesliverandspleencbahc57bl6f1afterasingleintravenousinjectionofzymosantreatedneutrophils AT vakozlov formationofsustainedantitumoreffectinmicesliverandspleencbahc57bl6f1afterasingleintravenousinjectionofzymosantreatedneutrophils |
_version_ |
1718417018359644160 |